Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 321

Sort by

Sort Order Select

Journal Articles

ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic

Joachim Yahalom, Bouthaina Shbib Dabaja, Umberto Ricardi, Andrea Ng, N. George Mikhaeel, Ivan R. Vogelius, Tim Illidge, Shunan Qi, Andrew Wirth, Lena Specht

Blood (2020) 135 (21): 1829–1832.

https://doi.org/10.1182/blood.2020006028

Published: 2020

Includes: Supplemental data

Journal Articles

Diagnosing HIT: the need for speed

Adam Cuker, Douglas B. Cines

Blood (2020) 135 (14): 1082–1083.

https://doi.org/10.1182/blood.2019004676

Published: 2020

Journal Articles

Treatment of unusual thrombotic manifestations

Maria Abbattista, Marco Capecchi, Ida Martinelli

Blood (2020) 135 (5): 326–334.

https://doi.org/10.1182/blood.2019000918

Published: 2020

Journal Articles

Barriers to the Use of Endari™ in an Urban Adult Sickle Cell Center

Ugochi Olivia Ogu, MD, Merin Thomas, NP, Florence Chan, PharmD, Gracy Sebastian, NP, Caterina P. Minniti, MD

Blood (2019) 134 (Supplement_1): 2287.

https://doi.org/10.1182/blood-2019-126666

Published: 2019

Journal Articles

Role of Genetic Evolution and Germline Mutations in SAMD9 and SAMD9L Genes

Jason R Schwartz, MD PhD, Marcin W. Wlodarski, MD PhD, Jeffery M. Klco, MD PhD

Blood (2019) 134 (Supplement_1): SCI-33.

https://doi.org/10.1182/blood-2019-121042

Published: 2019

Journal Articles

Chronic Myeloid Leukemia in Adolescents and Young Adults: A Single Institute Experience

Mohamed A Yassin, MBBS, MSc, Mohammad Abdul-Jaber Abdulla, MD, Prem Chandra, PhD, Mahmood B Aldapt, MD, Yasser Hamad, MSC, Susanna Jane Akiki, PhD, Nancy Kassem, BSC, Abdulqadir Jeprel Nashwan, BSN, MSN, Ula Nur, PhD

Blood (2019) 134 (Supplement_1): 5915.

https://doi.org/10.1182/blood-2019-126622

Published: 2019

Journal Articles

Landmark Response and Survival Analyses from 206 AML Patients Treated with Guadecitabine in a Phase 2 Study Demonstrate the Importance of Adequate Treatment Duration to Maximize Response and Survival Benefit. Survival Benefit Not Restricted to Patients with Objective Response

Karen W.L. Yee, MD, Gail J. Roboz, MD, Casey L. O'Connell, MD, Elizabeth A. Griffiths, MD, Raoul Tibes, MD PhD, Katherine J. Walsh, MD, Wendy Stock, MD, Guillermo Garcia-Manero, MD, Michael R. Savona, MD, Farhad Ravandi, MD, Naval G. Daver, MD, Elias Jabbour, MD, Todd L. Rosenblat, MD MS, Jean-Pierre Issa, MD, Xiang Yao Su, PhD, Mohammad Azab, MD, Hagop M. Kantarjian, MD

Blood (2019) 134 (Supplement_1): 3846.

https://doi.org/10.1182/blood-2019-129845

Published: 2019

Journal Articles

Development and Performance of Risk Stratification Models for AML Patients Utilizing ELN-2017 Guidelines and Additional Prognostic Factors: A SWOG Report

Blood (2019) 134 (Supplement_1): 2691.

https://doi.org/10.1182/blood-2019-124529

Published: 2019

Journal Articles

NUDT15 Variants Confer High Incidence of Secondary Malignancies of ALL in Children

Blood (2019) 134 (Supplement_1): 2751.

https://doi.org/10.1182/blood-2019-125713

Published: 2019

Journal Articles

ASXL1 / SRSF2 Co-Mutated Acute Myeloid Leukemia (AML): A Rare but Distinct Subpopulation with Dismal Outcomes

Daniel R. Richardson, MD MA, David M Swoboda, MD, Anastasia Ivanova, PhD, Steven M Johnson, MD, Jonathan Galeotti, MD MS, Sonia Esparza, MD, Onyee Chan, MD, Matthew C Foster, MD, Catherine C. Coombs, MD, Nathan D Montgomery, MD, David A Sallman, MD, Joshua F Zeidner, MD

Blood (2019) 134 (Supplement_1): 2598.

https://doi.org/10.1182/blood-2019-122929

Published: 2019

Journal Articles

Outcomes of Patients with Suboptimal /Warning Response to Tyrosine Kinase Inhibitors: A Comparison of the 2009 and 2013 Guidelines of the European Leukemianet

Hycienth O Ahaneku, MD MPH, PhD, Hagop M. Kantarjian, MD, Graciela M. Nogueras González, MPH, Gautam M. Borthakur, MD, Srdan Verstovsek, MD PhD, Tapan M. Kadia, MD, Naveen Pemmaraju, MD, Guillermo Garcia-Manero, MD, Marina Y Konopleva, MD PhD, Courtney D. DiNardo, MDMSc, Kiran Naqvi, MDMPH, Koji Sasaki, MD, Ghayas C. Issa, MD, Elias Jabbour, MD, Jorge E. Cortes, MD

Blood (2019) 134 (Supplement_1): 2930.

https://doi.org/10.1182/blood-2019-129108

Published: 2019

Journal Articles

Allogeneic Stem Cell Transplantation (alloHSCT) for Chronic Lymphocytic Leukemia (CLL) in the Era of Novel Agents

Lindsey E. Roeker, MD, Jennifer R. Brown, MD PhD, Peter Dreger, Oscar B Lahoud, MD, Toby A. Eyre, MBBChir, MRCP, Danielle M. Brander, MD, Alan Skarbnik, MD, Catherine C. Coombs, MD, Haesook T. Kim, PhD, Steven T Manchini, BS, Timothy J Voorhees, MD, Kim H. Orchard, MBBS,PhDFRCP,FRCPath, Harriet S Walter, Arvind K. Arumainathan, FRCPath, MBBS, MRCP,, Andrea Sitlinger, MD, Craig S. Sauter, MD, Sergio A Giralt, MD, Miguel-Angel Perales, MD, Anthony R. Mato, MDMSCE

Blood (2019) 134 (Supplement_1): 3321.

https://doi.org/10.1182/blood-2019-124140

Published: 2019

Journal Articles

Genome Data Allow in silico Pharmacogenetic Studies Using the Genetic Makeup of Both the Individual Patient As Well As the Disease

Manja Meggendorfer, PhD, Wencke Walter, PhD, Stephan Hutter, PhD, Constance Baer, PhD, Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2019) 134 (Supplement_1): 3360.

https://doi.org/10.1182/blood-2019-126580

Published: 2019

Journal Articles

Deviation from Guidelines in Use of Eltrombopag and Romiplostim in Clinical Practice for Children with Primary Immune Thrombocytopenia; Multi-Center Egyptian Experience

Mohsen Saleh Elalfy, MD, Tamer Hassan, MD, Khalid Elsayh, MD, Mohamed Maebid, MD, Hoda Hassab, MD, Rasha Elashry, MD, Mona El ghamrawy, MD, Mahmoud Elhawy, MD, Marwa Zakaria, MD, Mohamed Elshanshory, MD

Blood (2019) 134 (Supplement_1): 4907.

https://doi.org/10.1182/blood-2019-121994

Published: 2019

Journal Articles

The Peri-Operative Management of Anticoagulants: Systemic Review of Guidelines

Salma Shivji, MDFRCPC, Philip Chiang, MBSc, Lana A Castellucci, MD FRCPC, MSc, Elianna Saidenberg, MD FRCPC

Blood (2019) 134 (Supplement_1): 4974.

https://doi.org/10.1182/blood-2019-128395

Published: 2019

Journal Articles

2018 Evidence Base of Patient Blood Management - Recommendations from the First International Consensus Conference, Frankfurt/Main, Germany

Markus M. Mueller, MD, Hans van Remoortel, Patrick Meybohm, Kari Aranko, Mike Murphy, MD, Jeffrey L. Carson, MD, Erhard Seifried, MD PhD

Blood (2019) 134 (Supplement_1): 4982.

https://doi.org/10.1182/blood-2019-130601

Published: 2019

Journal Articles

Refining Blood Products Utilization: Every One (unit) Matters

Khaled Deeb, PhD MBA, MD, Chen Zhang, MD, Stanislav Ivanov, MD MPH, Eric Szu, MD, Louis Lit, MD

Blood (2019) 134 (Supplement_1): 4985.

https://doi.org/10.1182/blood-2019-121339

Published: 2019

Journal Articles

A Novel Automated Image Analysis System Using Deep Convolutional Neural Networks to Diagnose MDS

Konobu Kimura, Yoko Tabe, MD PhD, Tomohiko Ai, MD PhD, Akihiko Matsuzaki, Kumiko Nishibe, Miki Ebihara, Kimiko Kaniyu, Ikki Takehara, PhD, Kinya Uchihashi, PhD, Akimichi Ohsaka, MD PhD

Blood (2019) 134 (Supplement_1): 4670.

https://doi.org/10.1182/blood-2019-129524

Published: 2019

Journal Articles

Implementation of an Evidence-Based Care Pathway for Emergency Department Management of Sickle Cell Vaso-Occlusive Crisis Leads to Improved Clinical Outcomes

Jennifer Yui, MD, Scott A. Peslak, MD PhD, David Lambert, MD, Eric Russell, MD, Farzana Sayani, MD

Blood (2019) 134 (Supplement_1): 4678.

https://doi.org/10.1182/blood-2019-123868

Published: 2019

Journal Articles

Adherence to Infectious Disease Screening and Immunization Guidelines When Treating Non-Malignant Immune-Mediated Hematologic Disorders

Luis E Malpica Castillo, MD, Shannon Palmer, MS, Anqi Zhu, MS, Allison Deal, MS, Sheh-Li Chen, PharmD, Stephan Moll, MD

Blood (2019) 134 (Supplement_1): 792.

https://doi.org/10.1182/blood-2019-121340

Published: 2019

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic

Diagnosing HIT: the need for speed

Treatment of unusual thrombotic manifestations

Barriers to the Use of Endari™ in an Urban Adult Sickle Cell Center

Role of Genetic Evolution and Germline Mutations in SAMD9 and SAMD9L Genes

Chronic Myeloid Leukemia in Adolescents and Young Adults: A Single Institute Experience

Landmark Response and Survival Analyses from 206 AML Patients Treated with Guadecitabine in a Phase 2 Study Demonstrate the Importance of Adequate Treatment Duration to Maximize Response and Survival Benefit. Survival Benefit Not Restricted to Patients with Objective Response

Development and Performance of Risk Stratification Models for AML Patients Utilizing ELN-2017 Guidelines and Additional Prognostic Factors: A SWOG Report

NUDT15 Variants Confer High Incidence of Secondary Malignancies of ALL in Children

ASXL1 / SRSF2 Co-Mutated Acute Myeloid Leukemia (AML): A Rare but Distinct Subpopulation with Dismal Outcomes

Outcomes of Patients with Suboptimal /Warning Response to Tyrosine Kinase Inhibitors: A Comparison of the 2009 and 2013 Guidelines of the European Leukemianet

Allogeneic Stem Cell Transplantation (alloHSCT) for Chronic Lymphocytic Leukemia (CLL) in the Era of Novel Agents

Genome Data Allow in silico Pharmacogenetic Studies Using the Genetic Makeup of Both the Individual Patient As Well As the Disease

Deviation from Guidelines in Use of Eltrombopag and Romiplostim in Clinical Practice for Children with Primary Immune Thrombocytopenia; Multi-Center Egyptian Experience

The Peri-Operative Management of Anticoagulants: Systemic Review of Guidelines

2018 Evidence Base of Patient Blood Management - Recommendations from the First International Consensus Conference, Frankfurt/Main, Germany

Refining Blood Products Utilization: Every One (unit) Matters

A Novel Automated Image Analysis System Using Deep Convolutional Neural Networks to Diagnose MDS

Implementation of an Evidence-Based Care Pathway for Emergency Department Management of Sickle Cell Vaso-Occlusive Crisis Leads to Improved Clinical Outcomes

Adherence to Infectious Disease Screening and Immunization Guidelines When Treating Non-Malignant Immune-Mediated Hematologic Disorders

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only